Skip to main content

Migrations: Jan 30, 2009


The Massachusetts Life Sciences Center this week announced the addition of Jonathan Fleming, Doug Cole, and Jean George to the organization’s scientific advisory board, bringing the board’s total membership to fifteen.

Fleming is the managing general partner of Oxford Bioscience Partners. Prior to joining OBP in 1996, he was a founding general partner of MVP Ventures. He began his investment career with TVM Techno Venture Management. Fleming also co-founded Medica Venture Partners.

Cole is currently a general partner at Flagship Ventures. While at Flagship, Cole co-founded Ensemble Discovery with Noubar Afeyan and David Liu of Harvard University, and he served as chief executive officer of the company its initial stages.

He was previously medical director of Cytotherapeutics. Cole was then appointed program executive at Vertex Pharmaceuticals.

Jean George is a partner at Advanced Technology Ventures. Prior to joining ATV, George was a director at BancBoston Ventures. Previously, George held a variety of roles in marketing, product development, and business development at Genzyme, including vice president of global sales and marketing.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.